Literature DB >> 21442313

Systemic alterations in concentrations and distribution of plasma phospholipids in prostate cancer patients.

B Cvetković1, V Vučić, Z Cvetković, T Popović, M Glibetić.   

Abstract

The relationship between plasma levels of total phospholipids (PL) and/or PL fractions and neoplastic diseases are not fully understood. Therefore, the aim of this study was to analyze concentrations and distribution of plasma phospholipids in patients with prostate cancer (PCa) related to the Gleason score, clinical stage and pathologic grade of prostate cancer. We analyzed plasma phospholipids in 57 newly diagnosed, untreated PCa patients and in 43 age-matched healthy male subjects. Significantly lower (P < 0.01) levels of total plasma PL and all PL classes were found in PCa patients when compared with healthy subjects. The relative concentrations of PL fractions were also changed. Further decrease of total PL and PL fractions was found related to an increase of clinical stadium, pathologic grade, and Gleason score, with phosphatidylethanolamine as the most sensitive plasma PL, the level of which significantly decreased even at the first stage of PCa. Our results showed an altered plasma PL profile in PCa patients, which may contribute to monitoring of the disease progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21442313     DOI: 10.1007/s12032-011-9914-z

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  32 in total

1.  Application of 31P NMR spectroscopy in clinical analysis of changes of serum phospholipids in leukemia, lymphoma and some other non-haematological cancers.

Authors:  M Kuliszkiewicz-Janus; W Janus; S Baczyński
Journal:  Anticancer Res       Date:  1996 May-Jun       Impact factor: 2.480

2.  Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.

Authors:  D F Gleason; G T Mellinger
Journal:  J Urol       Date:  1974-01       Impact factor: 7.450

3.  Plasma and erythrocyte phospholipid fatty acids composition in Serbian hemodialyzed patients.

Authors:  Vanja Ristić; Vesna Tepsić; Danijela Ristić-Medié; Gordana Perunicić; Zorica Rasić; Marija Postić; Aleksandra Arsić; Vera Blazencić-Mladenović; Gordana Ristić
Journal:  Ren Fail       Date:  2006       Impact factor: 2.606

4.  Surface activity, lipid profiles and their implications in cervical cancer.

Authors:  A Preetha; R Banerjee; Nagraj Huilgol
Journal:  J Cancer Res Ther       Date:  2005 Jul-Sep       Impact factor: 1.805

Review 5.  Prostate cancer: screening, diagnosis and management in 2007.

Authors:  Robert L Grubb; Adam S Kibel
Journal:  Mo Med       Date:  2007 Sep-Oct

6.  Quantitative analysis of urinary phospholipids found in patients with breast cancer by nanoflow liquid chromatography-tandem mass spectrometry: II. Negative ion mode analysis of four phospholipid classes.

Authors:  Hye Kyeong Min; Gu Kong; Myeong Hee Moon
Journal:  Anal Bioanal Chem       Date:  2009-11-25       Impact factor: 4.142

Review 7.  Membrane lipid composition and cellular function.

Authors:  A A Spector; M A Yorek
Journal:  J Lipid Res       Date:  1985-09       Impact factor: 5.922

8.  Prostate needle biopsy reporting: how are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients?

Authors:  Mark A Rubin; Tarek A Bismar; Sarah Curtis; James E Montie
Journal:  Am J Surg Pathol       Date:  2004-07       Impact factor: 6.394

9.  Lipid profile as a prognostic factor in cancer patients.

Authors:  Z Cvetkovic; B Cvetkovic; M Petrovic; M Ranic; J Debeljak-Martarcic; V Vucic; M Glibetic
Journal:  J BUON       Date:  2009 Jul-Sep       Impact factor: 2.533

10.  Quantitative analysis of phosphatidylcholines and phosphatidylethanolamines in urine of patients with breast cancer by nanoflow liquid chromatography/tandem mass spectrometry.

Authors:  Hanna Kim; Hye Kyeong Min; Gu Kong; Myeong Hee Moon
Journal:  Anal Bioanal Chem       Date:  2009-02-05       Impact factor: 4.142

View more
  10 in total

1.  Global analysis of osteosarcoma lipidomes reveal altered lipid profiles in metastatic versus nonmetastatic cells.

Authors:  Jahnabi Roy; Payam Dibaeinia; Timothy M Fan; Saurabh Sinha; Aditi Das
Journal:  J Lipid Res       Date:  2018-11-30       Impact factor: 5.922

2.  Continuous blood purification ameliorates clinical signs and corrects the plasma phospholipid levels of patients with multiple organ dysfunction syndromes.

Authors:  Wei Wen; Kun Wang; Zhi-Ming Jiang; Zhong-Hui Zhang; Lei Zhou
Journal:  J Clin Lab Anal       Date:  2018-02-18       Impact factor: 2.352

3.  Lipidomics as a Diagnostic Tool for Prostate Cancer.

Authors:  Magdalena Buszewska-Forajta; Paweł Pomastowski; Fernanda Monedeiro; Justyna Walczak-Skierska; Marcin Markuszewski; Marcin Matuszewski; Michał J Markuszewski; Bogusław Buszewski
Journal:  Cancers (Basel)       Date:  2021-04-21       Impact factor: 6.639

4.  Serum metabolomics analysis for the progression of esophageal squamous cell carcinoma.

Authors:  Xia Li; Lihong Zhao; Mengke Wei; Jiali Lv; Yawen Sun; Xiaotao Shen; Deli Zhao; Fuzhong Xue; Tao Zhang; Jialin Wang
Journal:  J Cancer       Date:  2021-04-02       Impact factor: 4.207

5.  Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastases.

Authors:  Anna Raynor; Peter Jantscheff; Thomas Ross; Martin Schlesinger; Maurice Wilde; Sina Haasis; Tim Dreckmann; Gerd Bendas; Ulrich Massing
Journal:  Lipids Health Dis       Date:  2015-07-11       Impact factor: 3.876

6.  A novel three serum phospholipid panel differentiates normal individuals from those with prostate cancer.

Authors:  Nima Patel; Robert Vogel; Kumar Chandra-Kuntal; Wayne Glasgow; Uddhav Kelavkar
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

7.  Comparative Metabolomic and Lipidomic Analysis of Phenotype Stratified Prostate Cells.

Authors:  Tanya C Burch; Giorgis Isaac; Christiana L Booher; Johng S Rhim; Paul Rainville; James Langridge; Andrew Baker; Julius O Nyalwidhe
Journal:  PLoS One       Date:  2015-08-05       Impact factor: 3.240

8.  Lipidomic Impacts of an Obesogenic Diet Upon Lewis Lung Carcinoma in Mice.

Authors:  Sneha Sundaram; Petr Žáček; Michael R Bukowski; Aaron A Mehus; Lin Yan; Matthew J Picklo
Journal:  Front Oncol       Date:  2018-05-11       Impact factor: 6.244

9.  Identification of plasma lipid species as promising diagnostic markers for prostate cancer.

Authors:  Xiaoli Chen; Yong Zhu; Mayumi Jijiwa; Masaki Nasu; Junmei Ai; Shengming Dai; Bin Jiang; Jicai Zhang; Gang Huang; Youping Deng
Journal:  BMC Med Inform Decis Mak       Date:  2020-09-24       Impact factor: 2.796

10.  Integrated Analysis to Study the Relationship between Tumor-Associated Selenoproteins: Focus on Prostate Cancer.

Authors:  Francesca Capone; Andrea Polo; Angela Sorice; Alfredo Budillon; Susan Costantini
Journal:  Int J Mol Sci       Date:  2020-09-13       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.